Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:2.3.3.1 (citrate synthase)
 4,488 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A new, sensitive assay for the quantitative determination of AMP deaminase activity in human skeletal muscle is presented. The method is based on the determination of the direct product of the AMP deaminase reaction, the formed IMP, by high performance liquid chromatography (HPLC). In order to evaluate the relationship between AMP deaminase activity on the one hand and the contractile and metabolic characteristics of the muscle and the physical performance on the other, muscle biopsies were taken from 20 male subjects. The subjects also performed a 30 s sprint test on a cycle ergometer. The inter-individual variation in AMP deaminase activity was large, ranging from 5.4 to 27.4 microkat g-1 dry muscle. AMP deaminase was positively correlated with phosphofructokinase (PFK), the marker of the glycolytic capacity of the muscle, but there was no correlation with enzymes of oxidative metabolism, such as 3-hydroxyacyl-CoA dehydrogenase and citrate synthase, or with the activity of myokinase and lactate dehydrogenase. There was no significant correlation between AMP deaminase activity and the proportion of the different muscle fibre types. A weak positive correlation was found between the sprint performance and the AMP deaminase activity. In conclusion, the HPLC assay was found to be a fast, sensitive and reliable method for the quantitative determination of AMP deaminase activity in muscle. A direct relationship between AMP deaminase activity on the one hand and glycolytic capacity and sprint performance on the other was found. However, no relationship to oxidative capacity or contractile properties was found.
 ...
PMID:AMP deaminase in skeletal muscle of healthy males quantitatively determined by new assay. 803 9

Histochemical and biochemical analyses were performed on muscle biopsies obtained after racing from the gluteus muscle of 18 standardbred trotters. Fibre type composition and enzyme activities varied among the horses. The percentage of type IIB fibres showed a positive correlation to the lactate dehydrogenase activity and a negative correlation to the citrate synthase activity. ATP concentrations in whole muscle after racing showed a negative correlation to both lactate and IMP concentrations. Within individual fibres, ATP concentrations varied markedly, with some type II fibres having values as low as 1-5 mmol/kg d.w. and some fibres having values as high as 40-58 mmol/kg d.w., whereas mean ATP concentration for whole muscle was 18.3 +/- 7.7 mmol/kg d.w. Some fibres with low ATP concentrations revealed high IMP concentrations. Blood samples taken after racing showed high values for lactate, ammonia, and uric acid in plasma. Muscle AMP and ADP concentrations after racing were related to the horses placing in a race, with higher concentrations giving a lower placing. The results of this study show that adenine nucleotide breakdown in muscle is of great importance for energy release during racing, and that ATP and IMP concentrations may very markedly among individual fibres. Thus, metabolite analyses on whole muscle must be evaluated with caution, as this only represents a mean value for metabolic responses in different fibres during racing.
 ...
PMID:Metabolic response in skeletal muscle fibres of standardbred trotters after racing. 925 81

Both abnormalities in high energy phosphate metabolism and a decreased oxidative enzyme capacity have been reported in skeletal muscle of stable chronic obstructive pulmonary disease (COPD) patients. The first aim of this study was to investigate whether these findings are present in anterior tibialis muscle and whether or not they are associated. Abnormalities in mitochondrial structure and function as well as signs of myopathy have been found during corticosteroid treatment. The second aim of this study, therefore, was to investigate whether in COPD patients prolonged use of low dose prednisolone has effects on muscle energy metabolism and qualitative morphology. In a cross-sectional study 15 COPD patients (forced expiratory volume in one second (FEV1) 33+/-9 (mean+/-SD) % predicted) who were steroid-naive (CORT-) were compared with 10 healthy control subjects (HC) and with 14 COPD patients (FEV1 30+/-11 % pred), who had been using oral prednisolone for at least 1 yr (CORT+). It was found that adenosine triphosphate (ATP)/adenosine diphosphate was lower in CORT- compared to HC (5.7 versus 6.2, p=0.03). Inosine monophosphate was detected in 13 of 15 CORT- compared to 3 of 10 HC (p=0.004). However, although indications were found for an imbalance in production and utilization of ATP, comparing CORT- and HC, no differences in oxidative (citrate synthase and 3-hydroxy-acyl-coenzyme A dehydrogenase) and glycolytic (hexokinase, lactate dehydrogenase and phosphofructokinase) enzyme capacities were found. When, comparing steroid-treated and steroid-naive patient subgroups, no differences in the above mentioned parameters of muscle energy metabolism and of muscle qualitative morphology were found.
 ...
PMID:Muscle metabolic status in patients with severe COPD with and without long-term prednisolone. 1096 99